Clinical Trials in Pittsburgh

Showing 11181-11200 of 21,047 trials

Long-term Follow-Up for RGX-121

NCT04597385

RGX-121-5101 is the long-term follow-up study to the RGX-121-101 first in human study where participants received RGX-121, a gene therapy intended to deliver a functional copy of the iduronate-2-sulfatase gene (IDS) to the central nervous system. This study will evaluate the long-term safety and efficacy of RGX-121.

Mucopolysaccharidosis II

REGENXBIO Inc.12 participantsStarted Mar 2021

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML

NCT02708641

This study evaluates the effect of pembrolizumab on the duration of remission in acute myeloid leukemia. Pembrolizumab is given after complete remission is obtained in those with AML at least 60 years old who are not candidates for allogeneic stem cell transplant. The primary purpose of this study is determine if the time to relapse can be extended. Additionally, the safety and tolerability of pembrolizumab will be closely monitored.

Acute Myeloid Leukemia

Michael Boyiadzis12 participantsStarted Oct 2016

Pittsburgh, Pennsylvania, United States

TERMINATEDPhase 3< 1 mile

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

NCT03426345

This study will evaluate the safety and efficacy of relamorelin compared to placebo in participants with diabetic gastroparesis. Participants will report daily severity scores of their diabetic gastroparesis symptoms.

GastroparesisDiabetes Mellitus

Allergan311 participantsStarted Feb 2018

Athens, Alabama, United States • Birmingham, Alabama, United States • Foley, Alabama, United States +237 more locations

Long-term Follow-Up for RGX-121

A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

Find Trials by Condition in Pittsburgh

A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults

A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia

Natural History of Rett Syndrome & Related Disorders

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL)

rVWF IN PROPHYLAXIS

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Rare Diseases Clinical Research Network: Neurophysiological Correlates

Staccato Alprazolam and Photoparoxysmal Response

Perioperative Post-Prostatectomy Incontinence Home Telehealth Program

Biobanking of Rett Syndrome and Related Disorders

Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal Fillers

Motivation and Skills Support (MASS)